The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
17.92
+0.74 (4.31%)
At close: Jul 21, 2026, 4:00 PM EDT
17.92
0.00 (0.00%)
After-hours: Jul 21, 2026, 4:10 PM EDT
The Chemours Company Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, The Chemours Company stock has a consensus rating of "Buy" and an average price target of $25.33. The average 1-year stock price forecast is 41.35% higher than the current stock price, while the lowest is $21 (+17.19%) and the highest is $30 (+67.41%).
Price Target: $25.33 (+41.35%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for The Chemours Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Maintains $26 | Buy | Maintains | $26 | +45.09% | Jul 6, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $30 → $25 | Buy | Maintains | $30 → $25 | +39.51% | Jul 1, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $29 → $26 | Buy | Maintains | $29 → $26 | +45.09% | Jun 30, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $21 | Hold | Reiterates | $21 | +17.19% | Jun 25, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 18, 2026 |
Financial Forecast
Revenue This Year
6.05B
from 5.81B
Increased by 4.10%
Revenue Next Year
6.38B
from 6.05B
Increased by 5.57%
EPS This Year
1.28
from 0.95
Increased by 34.88%
EPS Next Year
2.24
from 1.28
Increased by 74.82%
EPS and Forward PE are based on non-GAAP adjusted numbers.